Melbourne, Mar 26, 2019 AEST (ABN Newswire) - Bluechiip Ltd (
ASX:BCT) provides the Company's broker presentation.
Summary
- World first, highly differentiated technology, with protected IP
- >$200M growing target market, very large adjacent markets
- Dramatically increasing partner pipeline, 32 developer kits sold
- Rapidly scaling production
- Partner opportunity conversion with three executed licence and supply agreements and Bluechiip Enabled products in manufacture
- Growing partner supply, over 300k chips delivered in CY18.
- Initial repeat revenues with sales up 136% Y.O.Y
- Orders in hand with a three year supply agreement over $US11.6 million ($A15.9 million) with Labcon
- $7.5m Capital Raised in September 2018
To view the full presentation, please visit:
http://abnnewswire.net/lnk/SRDL2ZZ1
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
